135 related articles for article (PubMed ID: 15227538)
1. Synthesis and biological evaluation of analogues of butyrolactone I and molecular model of its interaction with CDK2.
Braña MF; García ML; López B; de Pascual-Teresa B; Ramos A; Pozuelo JM; Domínguez MT
Org Biomol Chem; 2004 Jul; 2(13):1864-71. PubMed ID: 15227538
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases.
Braña MF; Cacho M; García ML; Mayoral EP; López B; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Lozach O; Meijer L
J Med Chem; 2005 Nov; 48(22):6843-54. PubMed ID: 16250643
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
[TBL] [Abstract][Full Text] [Related]
4. Isochaihulactone analogues: synthesis and anti-proliferative activity of novel dibenzylbutyrolactones.
Alizadeh BH; Foroumadi A; Emami S; Khoobi M; Panah F; Ardestani SK; Shafiee A
Eur J Med Chem; 2010 Dec; 45(12):5979-84. PubMed ID: 21035921
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II.
Desplat V; Moreau S; Gay A; Fabre SB; Thiolat D; Massip S; Macky G; Godde F; Mossalayi D; Jarry C; Guillon J
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):204-15. PubMed ID: 20222763
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors.
Virga KG; Zhang YM; Leonardi R; Ivey RA; Hevener K; Park HW; Jackowski S; Rock CO; Lee RE
Bioorg Med Chem; 2006 Feb; 14(4):1007-20. PubMed ID: 16213731
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking of aryl hydrazines and hydrazides for anticancer activity.
Gohil VM; Agrawal SK; Saxena AK; Garg D; Gopimohan C; Bhutani KK
Indian J Exp Biol; 2010 Mar; 48(3):265-8. PubMed ID: 21046979
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors.
Asaki T; Sugiyama Y; Hamamoto T; Higashioka M; Umehara M; Naito H; Niwa T
Bioorg Med Chem Lett; 2006 Mar; 16(5):1421-5. PubMed ID: 16332440
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic evaluation of novel paraconic acid analogs.
Le Floch C; Le Gall E; Léonel E; Martens T; Cresteil T
Bioorg Med Chem Lett; 2011 Dec; 21(23):7054-8. PubMed ID: 22004720
[TBL] [Abstract][Full Text] [Related]
11. In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivatives.
Sassatelli M; Bouchikhi F; Aboab B; Anizon F; Fabbro D; Prudhomme M; Moreau P
Anticancer Drugs; 2007 Oct; 18(9):1069-74. PubMed ID: 17704657
[TBL] [Abstract][Full Text] [Related]
12. Conformationally constrained analogues of diacylglycerol. 11. Ultrapotent protein kinase C ligands based on a chiral 5-disubstituted tetrahydro-2-furanone template.
Lee J; Wang S; Milne GW; Sharma R; Lewin NE; Blumberg PM; Marquez VE
J Med Chem; 1996 Jan; 39(1):29-35. PubMed ID: 8568819
[TBL] [Abstract][Full Text] [Related]
13. 1-Toluene-sulfonyl-3-[(3'-hydroxy-5'-substituted)-gamma-butyrolactone]-indoles: synthesis, COX-2 inhibition and anti-cancer activities.
Singh P; Mittal A; Bhardwaj A; Kaur S; Kumar S
Bioorg Med Chem Lett; 2008 Jan; 18(1):85-9. PubMed ID: 18061444
[TBL] [Abstract][Full Text] [Related]
14. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
Harmange JC; Weiss MM; Germain J; Polverino AJ; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; DiPietro L; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Martin MW; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Wang L; White RD; Whittington DA; Zanon R
J Med Chem; 2008 Mar; 51(6):1649-67. PubMed ID: 18324761
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of homoserine lactone derived ureas as antagonists of bacterial quorum sensing.
Frezza M; Castang S; Estephane J; Soulère L; Deshayes C; Chantegrel B; Nasser W; Queneau Y; Reverchon S; Doutheau A
Bioorg Med Chem; 2006 Jul; 14(14):4781-91. PubMed ID: 16574415
[TBL] [Abstract][Full Text] [Related]
18. Novel 5,7-disubstituted 6-amino-5H-pyrrolo[3,2-b]pyrazine-2,3-dicarbonitriles, the promising protein kinase inhibitors with antiproliferative activity.
Dubinina GG; Platonov MO; Golovach SM; Borysko PO; Tolmachov AO; Volovenko YM
Eur J Med Chem; 2006 Jun; 41(6):727-37. PubMed ID: 16675067
[TBL] [Abstract][Full Text] [Related]
19. From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors.
Jautelat R; Brumby T; Schäfer M; Briem H; Eisenbrand G; Schwahn S; Krüger M; Lücking U; Prien O; Siemeister G
Chembiochem; 2005 Mar; 6(3):531-40. PubMed ID: 15742375
[No Abstract] [Full Text] [Related]
20. Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.
Jacquemard U; Dias N; Lansiaux A; Bailly C; Logé C; Robert JM; Lozach O; Meijer L; Mérour JY; Routier S
Bioorg Med Chem; 2008 May; 16(9):4932-53. PubMed ID: 18439832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
